A vitamin D-derivative makes pancreatic tumors vulnerable to chemotherapy
9/28/2014
A synthetic derivative of vitamin D was found by Salk Institute researchers to collapse the barrier of cells shielding pancreatic tumors, making this seemingly impenetrable cancer much more...
Destroying chemo-resistant ovarian cancer cells
9/27/2014
Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50 percent of women who are diagnosed with the disease.
Destroying chemo-resistant ovarian cancer cells
9/27/2014
Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50 percent of women who are diagnosed with the disease.
There were only modest acute changes in cardiac biomarkers and electrocardiograms and there were no clinically significant cardiac events in patients with high-dose radiation exposure to the heart...
Cancer metastatis may be stopped in its tracks with the help of bacterial "communication system"
9/27/2014
Cancer, while always dangerous, truly becomes life-threatening when cancer cells begin to spread to different areas throughout the body.
Calming down immune cells could hold key to melanoma treatment
9/26/2014
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Improved survival for children with a leukemia subtype associated with poor prognosis
9/26/2014
St. Jude Children's Research Hospital study shows that adjusting treatment based on early response to chemotherapy boosts survival of young patients with Philadelphia chromosome-like acute...
Calming down immune cells could hold key to melanoma treatment
9/26/2014
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Research uncovers tumors self-protection mechanism
9/26/2014
Stephan Ladisch, MD, a hematologist-oncologist in the Center for Cancer and Immunology Research at Children's National Health System, and his laboratory have uncovered a mechanism by which tumors...
Discrepancies in access to new cancer drugs revealed
9/26/2014
Access to potentially life-extending cancer drugs varies significantly in different regions of the world, two new studies show at the ESMO 2014 Congress in Madrid, Spain.